A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the impact of JNJ-38518168 on rheumatoid arthritis
(RA) disease-related biomarkers in synovial biopsy tissue and blood in participants with
active RA despite methotrexate (MTX) therapy and to assess the safety and tolerability of
JNJ-38518168 over one year.